Daniel Vasella, (R) Chairman and CEO of Novartis and Former U.S. President Bill Clinton (L) speak during a news conference, at the Clinton Foundation headquarters in New York, July 17 2008. The Former President unveiled a deal with six Chinese and Indian companies to cut a key malaria drug price by a third and slash the price volatility of a vital ingredient by 70 percent. Artemisinin-based combination therapies, or ACT drugs, are recommended by the World Health Organization because of growing resistance to older treatments such as chloroquine. REUTERS/Brendan McDermid (UNITED STATES)
REUTERS/BRENDAN MCDERMID